Lapatinib plus Capecitabine for HER2-Positive Advanced-Stage Breast Cancer in Elderly Women: Review of the Anatolian Society of Medical Oncology (ASMO) Experience

BACKGROUND: The efficacy and safety of the lapatinib and capecitabine combination remain elusive in elderly patients with metastatic breast cancer (MBC), who progress after trastuzumab-based therapy. PATIENTS AND METHODS: A total of 26 patients with HER2-positive MBC were included in this retrospect...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Cetin, Bulent, Benekli, Mustafa, Dane, Faysal, Boruban, Cem, Gumus, Mahmut, Oksuzoglu, Berna, Kaplan, Mehmet A., Tufan, Gulnihal, Sevinc, Alper, Coskun, Ugur, Buyukberber, Suleyman
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: S. Karger GmbH 2013
Konular:
Original Article · Originalarbeit
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3971792/
https://ncbi.nlm.nih.gov/pubmed/24715846
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000346829
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller